Development of a Simplified Smell Test to Identify Patients with Typical Parkinson’s as Informed by Multiple Cohorts, Machine Learning and External Validation
Authors: Li Juan , Grimes Kelsey , Saade Joseph , Tomlinson Julianna J. , Mestre Tiago A. , Schade Sebastian , Weber Sandrina , Dakna Mohammed , Wicke Tamara , Lang Elisabeth , Trenkwalder Claudia , Salmaso Natalina , Frank Andrew , Ramsay Tim , Manuel Douglas ,   aSCENT-PD Investigators, Mollenhauer Brit , Schlossmacher Michael G. 
Published: August 2024

ABSTRACTBackgroundReduced olfaction is a common feature of patients with typical Parkinson disease (PD). We sought to develop and validate a simplified smell test as a screening tool to help identify PD patients and explore its differentiation from other forms of parkinsonism.MethodsWe used the Sniffin’ Sticks Identification Test (SST-ID) and the University of Pennsylvania Smell Identification Test (UPSIT), together with data from three case-control studies, to compare olfaction in 301 patients with PD or dementia with Lewy bodies (DLB) to 36 subjects with multiple system atrophy (MSA), 32 individuals with progressive supranuclear palsy (PSP) and 281 neurologically healthy controls. Individual SST-ID and UPSIT scents were ranked by area under the receiver operating characteristic curve (AUC) values for group classification, with 10-fold cross-validation. Additional rankings were generated by leveraging results from eight published studies, collectively including 5,853 unique participants. Lead combinations were further validated using (semi-)independent datasets. An abbreviated list of scents was generated based on those shared by SST-ID and UPSIT.FindingsWe made the following five observations: (i) PD and DLB patients generally had worse olfaction than healthy controls, as published, with scores for MSA and PSP patients ranking as intermediate. (ii) SST-ID and UPSIT scents showed distinct discriminative performances, with the top odorants (licorice, banana, clove, rose, mint, pineapple and cinnamon) confirmed by external evidence. (iii) A subset of only seven scents demonstrated a similar performance to that of the complete 16-scent SST-ID and 40-scent UPSIT kits, in both discovery and validation steps. Seven scents distinguished PD/DLB subjects from healthy controls with an AUC of 0.87 (95%CI 0.85-0.9) and PD/DLB from PSP/MSA patients with an AUC of 0.73 (95%CI 0.65-0.8) within the three cohorts (n=650). (iv) Increased age was associated with a decline in olfaction. (v) Males generally scored lower than females, although this finding was not significant across all cohorts.InterpretationScreening of subjects for typical Parkinson’s-associated hyposmia can be carried out with a simplified scent identification test that relies on as few as seven specific odorants. There, the discrimination of PD/DLB subjects vs. age-matched controls is more accurate than that of PD/DLB vs. PSP/MSA patients.FundingThis work was supported by: Parkinson Research Consortium; uOttawa Brain & Mind Research Institute; and the Aligning Science Across Parkinson’s Collaborative Research Network.Research in contextEvidence before this studyChronic hyposmia is a common feature of Parkinson disease (PD) and dementia with Lewy bodies (DLB), which often precedes motor impairment and cognitive dysfunction by several years; it is also frequently associated with α-synuclein aggregate formation in the bulb. The presence of hyposmia increases an individual’s likelihood of having -what has recently been proposed as- a neuronal synucleinopathy disease, by >24-fold. Despite the strong association of PD with reduced olfaction, little is understood about it clinically, such as whether it is affected by sex and age, and whether hyposmia of PD is associated with the same scent identification difficulty seen in other conditions that present with parkinsonism. Moreover, due to its time-consuming nature and traditional administration by healthcare workers, extensive olfactory testing is not routinely performed during neurological assessments in movement disorder clinics.Added value of this studyWe analyzed the performance of both the Sniffin’ Sticks Test kit and UPSIT battery to discriminate between healthy controls, patients with PD/DLB and those with MSA or PSP. Comparison to and juxtaposition with eight other published studies allowed for the generation of a markedly abbreviated smell identification test that unified both tests, as described. Group classification performance by each scent and its distractors was further analyzed using machine learning and advanced Item Response Theory methods. Relations between each scent tested, sex and age were analyzed for the first time. Our findings suggest concrete steps to be implemented that would allow for simplified, routine olfaction testing in the future.Implications of all the available evidenceOlfaction testing has emerged as an important neurological assessment part when examining subjects with Parkinson’s and those at risk of it. A simple, validated smell test containing fewer scents than current options could facilitate rapid testing of olfaction in clinic settings and at home, without supervision by healthcare workers. The usefulness of such a non-invasive test in population health screening efforts could be further enhanced when coupled to a self-administered survey that includes questions related to other risk factors associated with PD. As such, large-scale community screening and applications to routine practice in family doctors’ offices as well as in specialty clinics could be made operationally feasible and cost-effective.